載入中
NASDAQHealthcareMedical - Diagnostics & Research
最新資料
US$98.09
+US$2.68 · +2.81%
BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.
前收盤價
US$98.09
+US$2.68 · +2.81%
盤中時間採用ET。市場資料可能有所延遲。
BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.
日內區間
目前US$98.09
52週區間
目前US$98.09
盤中時間採用ET。市場資料可能有所延遲。
GoAI 評分
買進
估值
89
深度低估
情緒
51
多空交錯
風險
38
中等風險
動能
75
動能增強
完整 GoAI 研究
繼續查看更深入的依據、催化因素和風險。
BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.
日內區間
目前US$98.09
52週區間
目前US$98.09
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 |
|---|---|---|---|
| 營收 | 3.05億 USD | 1.53億 USD | 7172.9萬 USD |
| 銷貨成本 | 9665.4萬 USD | 7166.7萬 USD | 5442.1萬 USD |
| 毛利 | 2.08億 USD | 8091.5萬 USD | 1730.8萬 USD |
| 研究與開發 | 4938.4萬 USD | 3659.6萬 USD | 2241.4萬 USD |
| 銷售、一般及管理費用 | 1.43億 USD | 9146.5萬 USD | 6438.9萬 USD |
| 營業費用 | 1.92億 USD | 1.28億 USD | 8680.3萬 USD |
| 利息收入 | 775萬 USD | 581.9萬 USD | 345.6萬 USD |
| 利息支出 | 9.5萬 USD | 238.6萬 USD | 327.2萬 USD |
| 折舊和攤銷 | 1190.7萬 USD | 1168.8萬 USD | 646.3萬 USD |
| 營業利益 | 1602.3萬 USD | −4714.6萬 USD | −6949.5萬 USD |
| 淨利 | 745.4萬 USD | −4157萬 USD | −8268.3萬 USD |
公司資料更新於 2026年10月12日。
近期已公布業績
近期已公布業績
報告持有此股票曝險的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI6580.92萬0.00%2.3兆 USD0.03%US$381.94+0.63%
Vanguard Morningstar Small-Cap ETFVB4751.72萬0.03%1853億 USD0.03%US$289.48+0.64%
Vanguard Morningstar Small-Cap Value ETFVBR1509.95萬0.02%682億 USD0.05%US$234.43+0.22%
Vanguard Morningstar Small-Cap Growth ETFVBK1361.13萬0.03%447億 USD0.05%US$344.74+1.22%
Schwab U.S. Small-Cap ETFSCHA1119.5萬0.05%218.24億 USD0.03%US$32.79+0.40%
F/M Emerald Life Sciences Innovation ETFLFSC529.68萬4.49%1.18億 USD0.79%US$42.6071+2.24%
Vanguard Extended Market ETFVXF477.2萬0.00%954億 USD0.05%US$235+0.80%
iShares U.S. Healthcare Providers ETFIHF370.49萬0.28%13.54億 USD0.37%US$56.76+1.74%Vanguard Morningstar Total Stock Market ETFVTIVanguard Morningstar Small-Cap ETFVBVanguard Morningstar Small-Cap Value ETFVBRVanguard Morningstar Small-Cap Growth ETFVBKSchwab U.S. Small-Cap ETFSCHAF/M Emerald Life Sciences Innovation ETFLFSCVanguard Extended Market ETFVXFiShares U.S. Healthcare Providers ETFIHFAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
